- DAX underperforms European indices; DE40 loses 0.2%. Zalando (ZAL.DE), Lufthansa Airlines (LHA.DE), freight company Hapag-Lloyd (HLAG.DE) lose the most heavily
- Siemens AG (SIE.DE) near ATH after contract with British railroads. Bayer (BAYN.DE) without much reaction to the initial success of the drug Elinzanetant
- Zalando downgraded to Neutral at Arete; target price €35; Bernstein analysts raise recommendation to 'overweight' on Beiersdorf
- German industrial production up surprisingly, despite weaker orders reading, reported yesterday
The mood on the German stock market remains subdued today, although the index is fluctuating near historic highs. Investors also learned surprisingly strong industrial production data. Industrial production for November rose 1.5% m/m, against expectations of 0.5% m/m and the previous reading of -1.0% m/m. Exports rose 2.1% m/m, against expectations of 2.0% m/m and the previous 2.8% m/m decline. Imports fell unexpectedly by 3.3% m/m, with an expected increase of 0.7% m/m and with a previous decline of 0.1% m/m It is worth mentioning that in September we had a massive increase in transportation orders, which is most likely at this point projecting a recovery in industrial production. Since September, however, orders have been clearly declining.
DE40 (D1 interval)
The DAX contracts are struggling to break out above the 50-session average (orange line), which would potentially open the way for the bulls to make new highs.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSource: xStation5
Zalando (ZAL.DE)
Zalando is already down nearly 15% from local maxima; however, the stock could still realize a 1:1 correction scenario, with the price currently reaching the lower range in a potentially upward pattern.
Source: xStation5
Source: Bloomberg Finance L.P.
Companies news
Bayer's (BAYN.DE) drug Elinzanetant meets all primary and secondary targets in the Phase III OASIS 4 trial for the treatment of moderate to severe vasomotor symptoms caused by breast cancer treatment. The stock, however, is gaining slightly, currently rising less than 0.5%.
- The drug's 2024 52 safety profile appeared to be consistent with previously published data in postmenopausal women with VMS.
- The positive results of the OASIS 4 study complement the positive results of the OASIS 1, 2 and 3 studies and further confirm the efficacy and safety of the drug Elinzanetant, the company reported.
Mercedes (MBG.DE) shares are losing 0.5%, although the company's Mercedes-India division posted its best-ever annual sales in 2024. The company now plans to debut 8 new models in India, including electrics, after 14 models debuted in 2024. In 2024, the company sold 19,565 models in India; that's up 12% from 17,408 units in 2023.
- Mercedes reported that 25% of vehicles sold in India last year were high-end models. In the second half of 2024, however, market growth in India slowed to 2-3%, with Mercedes' sales increasing precisely due to strong demand for premium vehicles. Currently, the company is fulfilling orders for 2,000 models in the Indian market.
- Mercedes managers point to favorable business circumstances in the country, and a positive currency effect. On the other hand, the company is concerned about geopolitical risks and tariffs. Sales of Mercedes electrics in India grew 94% year-on-year in 2024; and the share of all EVs in Mercedes' total sales increased from 2.5% to 6%. Mercedes India aims to open 20 new showrooms in India, up from 125 today, in 2025. The automaker managed to sell 50,000 cars in India in its first 20 years; sales have been accelerating in recent years.
Siemens (SIE.AG) secures additional 4 HS2 Ltd infrastructure contracts, valued at €670 million; orders will be fulfilled by Siemens Mobility as part of the Rail Systems Alliance. The company's shares are gaining less than 0.2%.
- The work will include the new UK High Speed Rail (ETCS) from London to the West Midlands. The company has formed a venture with Costain Group PLC to provide high-voltage power systems. The two companies will also maintain and operate the system for at least seven years; Siemens will provide technical support for at least 15 years. Implementation will begin in 2025. The goal of the project will be to improve network performance and minimize delays.
Siemens AG shares (SIE.DE)
Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
